Coronavirus vaccine update: Pfizer, German partner seek emergency approval, what’s next?2 min read . Updated: 21 Nov 2020, 11:16 AM IST
- In a major step toward providing protection against the deadly virus, Pfizer became the first to do so in the US or Europe as the Covid-19 pandemic rages around the world
- Pfizer's application to the FDA comes days after the global drugmakers reported final trial results that showed the vaccine was 95% effective in preventing Covid
At a time when we all are desperately waiting for a vaccine to curtail the spread of the novel coronavirus, the American pharmaceutical company confirmed that Pfizer Inc and its German partner BioNTech have formally asked the US Food and Drug Administration (FDA) for emergency use authorisation for their Covid-19 vaccine.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more